home

conference

maui-derm

Maui Derm

Articles

Regenerative medicine is still in its infancy, but patient demand and ease of use are growing its popularity among dermatologists. However, regulatory issues raise concerns. 
 

Regenerative Medicine Gaining Popularity  

Data from trials show tazarotene 0.045% lotion is an effective treatment for moderate to severe facial acne and improves acne-related QOL in patients across BMI categories. 


Tazarotene Excels Across BMI Categories

A presentation from Maui Derm Live 2021 featured insights on new drugs and data in acne.









2021 Acne Updates: New Drugs and Research

Expert offers tips on understanding and complying with regulations governing this growing sector.

Quick Guide to Regulatory Issues for Regenerative Aesthetic Medicine

Diagnosis, risk assessment and treatment of congenital melanocytic nevi (CMN), as well as melanoma, require specific strategies for pediatric patients.

Optimize Risk, Management of Pigmented Lesions in Pediatric Patients

This formulation could be first FDA-approved single-agent E-BPO prescription drug to treat rosacea. 

New E-BPO Improves Rosacea 

The limited armamentarium of systemic therapies for atopic dermatitis has already been expanded with the approval of dupilumab. Forthcoming systemic therapies are expected to include a new biologic and three new Janus kinase (JAK) inhibitors. 

Systemic Therapy Advances for AD

Update tracks trending factors changing the treatment landscape. 

New Research Addresses Rosacea Challenges 

Trichometric analysis helps evaluate whether treatment is working for patients experiencing hair loss and what adjustments need to be made to the regimen.

Quantifying is Key to Effective Hair Loss Treatment

John Jesitus is a medical writer based in Westminster, CO.

This is the first overhaul in a quarter century that simplifies evaluation and management and increases flexibility.